Area of research
Oncology · Infectious Diseases
Research interest
Research interests include COVID-19 and healthcare impacts, Cancer Immunotherapy and Biomarkers, COVID-19 Clinical Research Studies, and Melanoma and MAPK Pathways.
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
Time-Dependent COVID-19 Mortality in Patients With Cancer
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Determinants of enhanced vulnerability to COVID-19 in UK cancer patients: a European Study
UCL Discovery (University College London) 2021cited by 0position: middle